Frenel JS, Kim JW, Aryal N, Asher R, et al. Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial. Ann Oncol 2022 Jun 27. pii: S0923-7534(22)01740.
PMID: 35772665